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Aims and objectives
Primary ciliary dyskinesia (PCD) is a genetic disease in which abnormal or absent beating of cilia hinder normal mucociliary clearance. Among subjects with non-cystic fibrosis bronchiectasis 1-18% have an underlying diagnosis of congenital conditions including PCD and it is suspected that there is under-recognition of this disease. Diagnosis of PCD is complex including electron microscopy and video microscopy analysis of nasal mucosa cells. Aim of this study was to evaluate special features of primary ciliary dyskinesia in computed tomography to facilitate diagnosis in the cohort of bronchiectasis.
Methods and materials
111 CT examinations in patients with bronchiectasis were scored for bronchiectasis (according to Reiff; extent, severity, type and bronchial wall thickening separately for each lobe), associated findings (mucus plugging, tree in bud, atelectasis, consolidations, ground glass opacities, tree in bud pattern) and situs inversus. Patients with PCD (n=28) were compared to patients with other underlying diseases (n=83) with Chi square test (binary data) and Mann-Whitney-U-test (ordinal data). Based on the predominant findings in patients with PCD a simple score was developed including bronchiectasis predominant in the middle and lower lobes, atelectasis of the middle or lower lobe, previous resection of a middle (lingula) or lower lobe and situs inversus. ROC-analysis was performed to differentiate between patients with PCD and those with other underlying diseases.
Results
In patients with PCD, the extent and severity of bronchiectasis were higher in the middle and lower lobes and significantly lower in the upper lobes (p<0.001) compared to bronchiectasis-patients without PCD. Bronchial wall thickening in the middle lobes (p=0.001), tree in bud pattern (p=0.047) and situs inversus (p<0.001) were also significantly higher in patients with PCD compared to those with other underlying diseases. The score for PCD including bronchiectasis predominant in the middle and lower lobes, atelectasis of the middle or lower lobe, previous resection of a middle (lingula) or lower lobe and situs inversus was significantly higher in patients with PCD (p=0.001). ROC-analysis differentiating between bronchiectasis patients with PCD and those with other underlying diseases revealed an area under the curve of 0.801 (p=0.001). Using a threshold of 2, the test has a good sensitivity (0.71) and negative prediction value (0.90) but only a low specifity (0.17).
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Conclusion
CT imaging features of bronchiectasis differ significantly in patients with PCD and other underlying diseases. CT imaging features and a simple CT-score for PCD are valuable diagnostic tools for PCD.
